Clinical Trials Browser

Active not recruiting × Recurrence × NET × Clear all

NCT06148636 2025-11-04

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

Phase EARLY_PHASE1 Active not recruiting

Adenoma, Islet Cell, Recurrence, Neuroendocrine Tumors